Quality of life complements traditional outcome measures in immune-mediated polyneuropathies

Neurology

Volumn 59, Issue 1, 2002, Pages 84-91

  Merkies, I S J ^a   Schmitz, P I M ^a   Van der Meche F G A ^a   Samijn, J P A ^a   Van Doorn, P A ^a  

^a Sint Elisabeth Hospitaal   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATING DISEASE; FEMALE; GUILLAIN BARRE SYNDROME; HEALTH STATUS; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POLYNEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; STANDARDIZATION; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0037046983     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.1.84     Document Type: Article

References (37)

1. Outcome research in neurology: Incorporating health-related quality of life
2. Development of a health-related quality of life measure for peripheral neuropathy
3. Residual health status after Guillain-Barré syndrome
4. Randomized trial of interferon β-1a in chronic inflammatory demyelinating polyradiculoneuropathy
5. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies
6. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies
7. Evaluating neurological outcome measures: The bare essentials
8. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations
9. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results form the IQOLA project
10. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré Syndrome
11. Assessment of current diagnostic criteria for Guillain-Barré Syndrome
12. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
13. Paraproteinaemic neuropathies
14. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies
15. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome
16. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over study
17. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy
18. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: Clinical and laboratory characteristics associated with improvement
19. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
20. The restricted cubic spline hazard model
21. Comparisons of five health status instruments for orthopedic evaluation
22. Effect sizes for interpreting changes in health status
23. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36: Its association with disease activity and damage in patients with systemic lupus erythematosus
24. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: A controlled, population-based study
25. Physical and psychosocial function in rheumatoid arthritis
26. Coping with illness in myasthenia gravis
27. Adaptive responses among Dutch elderly: The impact of eight chronic medical conditions on health-related quality of life
28. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms
29. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study
30. Guillain-Barré syndrome: Psychosocial aspects of management
31. Social support, rheumatoid arthritis and quality of life: Concepts, measurements and research
32. Fatigue in immune-mediated polyneuropathies
33. Usefulness of the SF-36 health survey in measuring health outcomes in the depressed elderly